NEUROABILITY LIMITED

Company Registration Number:
14180654 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

NEUROABILITY LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

NEUROABILITY LIMITED

Company Information

for the Period Ended 31 March 2025




Director: Taher Dhuliawala
Fatema Mitaiwala
Registered office: 29
Waterloo Crescent
Wigston
England
LE18 3QJ
Company Registration Number: 14180654 (England and Wales)

NEUROABILITY LIMITED

Balance sheet

As at 31 March 2025


Notes

2025
£

2024
£
Fixed assets
Tangible assets: 4 659 1,199
Total fixed assets: 659 1,199
Current assets
Debtors: 5,054 4,019
Cash at bank and in hand: 8,861 6,331
Total current assets: 13,915 10,350
Creditors: amounts falling due within one year: ( 7,860 ) ( 4,968 )
Net current assets (liabilities): 6,055 5,382
Total assets less current liabilities: 6,714 6,581
Accruals and deferred income: ( 1,000 ) ( 1,500 )
Total net assets (liabilities): 5,714 5,081

The notes form part of these financial statements

NEUROABILITY LIMITED

Balance sheet continued

As at 31 March 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 5,712 5,079
Shareholders funds: 5,714 5,081

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 December 2025
And Signed On Behalf Of The Board By:

Name: Taher Dhuliawala
Status: Director

The notes form part of these financial statements

NEUROABILITY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Revenue is recognized as at the point of service and accrued for in the same period.

    Tangible fixed assets depreciation policy

    Depreciation policy for Plant & Equipment is based on 25% SL.
    Depreciation policy for Comp Equipment is based on 33% SL.

NEUROABILITY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 2 2

NEUROABILITY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No

NEUROABILITY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Tangible Assets

Total
Cost £
At 01 April 2024 1,739
Additions -
Disposals -
Revaluations -
Transfers -
At 31 March 2025 1,739
Depreciation
At 01 April 2024 540
Charge for year 540
On disposals -
Other adjustments -
At 31 March 2025 1,080
Net book value
At 31 March 2025 659
At 31 March 2024 1,199